Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heartflow (HTFL) Depreciation & Amortization (CF) (2024 - 2025)

Heartflow's quarterly Depreciation & Amortization (CF) came in at $1.4 million in Q4 2025, down 13.83% year-on-year from $1.6 million in Q4 2024, and up 289.49% quarter-over-quarter from $352000.0 in Q3 2025.

Heartflow has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $1.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 13.83% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $3.7 million (up 53.21% YoY), and the FY2025 full-year result was $5.4 million, up 1.53% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 stood at $1.4 million, up from $352000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.6 million in Q4 2024, with the low at $352000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 8.32 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 39.09 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 38.21 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 1.17 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 4.13 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 41.45 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 9.96 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 146,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 18.60 Mn
10 Heartflow 1.15 Bn 974.90 Mn 39.06 Mn 1.37 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 352,000.00
Sep 30, 2025 352,000.00
Jun 30, 2025 389,000.00
Jun 30, 2025 389,000.00
Dec 31, 2024 1.59 Mn
Dec 31, 2024 1.59 Mn
Sep 30, 2024 413,000.00
Sep 30, 2024 413,000.00
Jun 30, 2024 413,000.00
Jun 30, 2024 413,000.00